3-phenoxybenzaldehyde cyanohydrin

We are 3-phenoxybenzaldehyde cyanohydrin CAS:52315-06-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:3-phenoxybenzaldehyde cyanohydrin
CAS.NO:52315-06-7
Synonyms:3-phenoxybenzaldehyde cyanohydrin
(S)-2-hydroxy-(3-phenoxy)phenylacetonitrile
3-Phenoxybenzaldehyde cyanohydrin
(S)-(cyano)(3-phenoxyphenyl)methanol
(3-Phenoxyphenyl)glycolonitrile
 
Physical and Chemical Properties:
Density 1.22g/cm3
Boiling Point 399.8ºC at 760mmHg
Molecular Formula C14H11NO2
Molecular Weight 225.24300
Flash Point 195.6ºC
Index of Refraction 1.606
 
Specification:
Appearance:Yellow to light brown viscous liquid
Assay:≥95.0%
Unreacted MPBAD:≤2.0%
Free CN:≤1.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Decamethrin(CAS:52918-63-5)、Cymperator(CAS:52315-07-8)、Phenvalerate(CAS:51630-58-1)、Flucythrinate(CAS:70124-77-5)、Cyhalothrin(CAS:91465-08-6) and Cyphenothrin(CAS:39515-40-7).

3-phenoxybenzaldehyde cyanohydrin


Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.77295-58-0 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity. 2,6-dicloro-3-yodopiridina CAS:148493-37-2 If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.Ácido 4-metoxifenilacético CAS:104-01-8 Due to the time-consuming process of EIA approval and EIA acceptance for newly-built projects, and environmental protection supervision policies are becoming increasingly tight, the company strives to improve capacity utilization through reasonable equipment layout when designing and constructing capacity.In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.

Related Products
Product Name
2,3-Difluoro-6-nitrophenol View Details
3-Methylpiperidine View Details
3-Aminophthalic acid View Details
2,3-Dichlorobenzotrifluoride manufacturer Potassium Nitrate manufacturer Nα,Nε-Di-Boc-L-lysine Dicyclohexylammonium Salt manufacturer 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl 2-methylprop-2-enoate Cas:1996-88-9 manufacturer Methyl Valeraldehyde manufacturer